MedPath
NMPA Approval

Erlotinib Hydrochloride Tablets

国药准字H20213491

June 16, 2021

Drug Information

盐酸厄洛替尼片

片剂

100mg

化学药品

June 16, 2021

Company Information

Applicant Company

南京市江北新区长芦街道崇福路310号

Manufacturing Company

南京经济技术开发区恒竞路28号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸厄洛替尼片 - NMPA 批准文号 | MedPath